sertraline has been researched along with Glioma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aljaeid, B; El-Say, KM; Harbi, I; Zidan, AS | 1 |
| Kováru, F; Kovárů, H; Lisá, V | 1 |
2 other study(ies) available for sertraline and Glioma
| Article | Year |
|---|---|
Glycosylated Sertraline-Loaded Liposomes for Brain Targeting: QbD Study of Formulation Variabilities and Brain Transport.
Topics: Animals; Biological Transport; Blood-Brain Barrier; Brain; Brain Neoplasms; Cell Line, Tumor; Chemistry, Pharmaceutical; Drug Delivery Systems; Glioma; Glucose Transporter Type 1; Liposomes; Mice; Sertraline | 2016 |
Effect of fluoxetine and adenosine receptor NECA agonist on G alpha q/11 protein of C6 glioma cells.
Topics: Adenosine-5'-(N-ethylcarboxamide); Animals; Brain Neoplasms; Cell Line, Tumor; Citalopram; Depression; Fluoxetine; Glioma; GTP-Binding Protein alpha Subunits, Gq-G11; Neurons; Purinergic P1 Receptor Agonists; Rats; Selective Serotonin Reuptake Inhibitors; Sertraline; Signal Transduction | 2012 |